We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIT
2901
DELISTED
CIT Group Inc.
CIT
$340K ﹤0.01%
6,467
+402
+7% +$20.3K
BHK icon
2902
BlackRock Core Bond Trust
BHK
$664M
$339K ﹤0.01%
24,082
+674
+3% +$9.15K
PRGO icon
2903
Perrigo
PRGO
$1.75B
$339K ﹤0.01%
7,121
-899
-11% -$42.8K
LGF.A
2904
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$339K ﹤0.01%
27,706
+1,626
+6% +$23.4K
ZWS icon
2905
Zurn Elkay Water Solutions
ZWS
$8.47B
$338K ﹤0.01%
23,210
-2,991
-11% -$40.3K
MUE
2906
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$336K ﹤0.01%
26,732
+14
+0.1% +$172
PRTK
2907
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$336K ﹤0.01%
84,123
-5,742
-6% -$27.3K
YELP icon
2908
Yelp
YELP
$1.35B
$335K ﹤0.01%
9,810
-5,730
-37% -$198K
TSC
2909
DELISTED
TriState Capital Holdings, Inc.
TSC
$335K ﹤0.01%
15,693
+770
+5% +$16.9K
ICLN icon
2910
iShares Global Clean Energy ETF
ICLN
$2.08B
$333K ﹤0.01%
31,344
-111,376
-78% -$1.13M
OTEX icon
2911
Open Text
OTEX
$5.99B
$333K ﹤0.01%
8,078
-39
-0.5% -$1.55K
BPY
2912
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$333K ﹤0.01%
17,670
+1,561
+10% +$31.1K
RARX
2913
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$333K ﹤0.01%
11,090
-1,260
-10% -$28.9K
BSL
2914
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$171M
$332K ﹤0.01%
19,679
-146
-0.7% -$2.45K
ENFR icon
2915
Alerian Energy Infrastructure ETF
ENFR
$521M
$332K ﹤0.01%
15,414
-515
-3% -$11.1K
MYFW icon
2916
First Western Financial
MYFW
$305M
$332K ﹤0.01%
25,000
SEB icon
2917
Seaboard Corp
SEB
$4.06B
$331K ﹤0.01%
80
RIG icon
2918
Transocean
RIG
$6.33B
$330K ﹤0.01%
51,550
-14,882
-22% -$111K
XYLD icon
2919
Global X S&P 500 Covered Call ETF
XYLD
$3.28B
$330K ﹤0.01%
6,765
-1,906
-22% -$91.8K
NAV
2920
DELISTED
Navistar International
NAV
$330K ﹤0.01%
9,585
-1,727
-15% -$57.3K
CGEN icon
2921
Compugen
CGEN
$221M
$329K ﹤0.01%
83,432
-400
-0.5% -$1.42K
OLBK
2922
DELISTED
Old Line Bancshares, Inc.
OLBK
$329K ﹤0.01%
12,354
MITT
2923
TPG Mortgage Investment Trust
MITT
$201M
$328K ﹤0.01%
6,884
-67
-1% -$3.3K
PBJ icon
2924
Invesco Food & Beverage ETF
PBJ
$106M
$327K ﹤0.01%
9,781
-565
-5% -$18.9K
SYKE
2925
DELISTED
SYKES Enterprises Inc
SYKE
$327K ﹤0.01%
11,896
-46,137
-80% -$1.24M

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.